Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles

Author:

Tidwell Tia R.1,Røsland Gro23,Tronstad Karl Johan2,Søreide Kjetil456,Hagland Hanne R.1ORCID

Affiliation:

1. Department of Chemistry, Bioscience and Environmental Engineering University of Stavanger Stavanger Norway

2. Department of Biomedicine University of Bergen Bergen Norway

3. Department of Oncology and Medical Physics Haukeland University Hospital Bergen Norway

4. Department of Gastrointestinal Surgery Stavanger University Hospital Stavanger Norway

5. Department of Clinical medicine University of Bergen Bergen Norway

6. Gastrointestinal Translational Research Group Stavanger University Hospital Stavanger Norway

Abstract

AbstractBackgroundIn vitro drug screening that is more translatable to the in vivo tumor environment can reduce both time and cost of cancer drug development. Here we address some of the shortcomings in screening and show how treatment with 5‐fluorouracil (5‐FU) in 2D and 3D culture models of colorectal cancer (CRC) and pancreatic ductal adenocarcinomas (PDAC) give different responses regarding growth inhibition.MethodsThe sensitivity of the cell lines at clinically relevant 5‐FU concentrations was monitored over 4 days of treatment in both 2D and 3D cultures for CRC (SW948 and HCT116) and PDAC (Panc‐1 and MIA‐Pa‐Ca‐2) cell lines. The 3D cultures were maintained beyond this point to enable a second treatment cycle at Day 14, following the timeline of a standard clinical 5‐FU regimen.ResultsEvaluation after one cycle did not reveal significant growth inhibition in any of the CRC or PDAC 2D models. By the end of the second cycle of treatment the CRC spheroids reached 50% inhibition at clinically achievable concentrations in the 3D model, but not in the 2D model. The PDAC models were not sensitive to clinical doses even after two cycles. High content viability metrics point to even lower response in the resistant PDAC models.ConclusionThis study reveals the limitations of testing drugs in 2D cancer models and short exposure in 3D models, and the importance of using appropriate growth inhibition analysis. We found that screening with longer exposure and several cycles of treatment in 3D models suggests a more reliable way to assess drug sensitivity.

Publisher

Wiley

Reference42 articles.

1. Discovery & Development Services | Developmental Therapeutics Program (DTP).NCI‐60 Human Tumor Cell Lines Screen. Accessed fromhttps://dtp.cancer.gov/discovery_development/nci‐60/default.htm2021.

2. The NCI60 human tumour cell line anticancer drug screen

3. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array

4. Inconsistency in large pharmacogenomic studies

5. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma;Sutherland RM;Cancer Res,1986

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3